Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Docosahexaenoic Acid in the Treatment of Autism

This study has been completed.
Sponsor:
Collaborator:
DSM Nutritional Products, Inc.
Information provided by:
Mayo Clinic
ClinicalTrials.gov Identifier:
NCT00577447
First received: December 18, 2007
Last updated: May 20, 2011
Last verified: May 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2007
  Primary Completion Date: September 2007 (Final data collection date for primary outcome measure)